2026: reflecting on the last year’s research progress and looking at what’s ahead
2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much...
Learn more
UK sleepwalking into Parkinson’s pandemic
Cure Parkinson’s has today published the results from our recent survey revealing an alarming lack of knowledge about the world’s fastest growing neurological condition. We are dedicated to finding a cure for Parkinson’s and are calling for urgent action.
Jon Goodwin is an astronaut, and has Parkinson’s
In the first private astronaut mission of its kind, Jon Goodwin was a member of the passenger crew on board Virgin Galactic’s VSS Unity. Jon was diagnosed with Parkinson’s in 2014 and, now aged 80, was the second person with the condition to fly to…
World Parkinson Congress 2023
There is no other meeting in the Parkinson’s space that is quite like the World Parkinson Congress! Hosted for the first time in 2004, the World Parkinson Congress (WPC) is an inclusive international Parkinson’s meeting that draws delegates from around the globe representing a broad…
Helen Matthews to be new CEO of Cure Parkinson’s
We are delighted to announce that Helen Matthews will be taking over as CEO of Cure Parkinson’s later this summer. As our current Deputy CEO and former COO, Helen has been a driving force behind the charity since it was formed over 17 years ago,…
Cure Parkinson’s CEO discusses hope for a cure with the Movers & Shakers
The latest episode of the hugely popular Movers & Shakers podcast features our very own Will Cook, CEO of Cure Parkinson’s. This episode, which also features University College London’s Professor Tom Foltynie, looks at the progress of ongoing clinical work in the world of Parkinson’s research…